Lsv Asset Management Corcept Therapeutics Inc Transaction History

Lsv Asset Management

$45.3 Billion
Q3 2025

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$24.7 - $29.12 $42,335 - $49,911	-1,714 Reduced 21.76%	6,163 $158,000
Q2 2022 Aug 10, 2022	SELL	$17.33 - $25.3 $28,230 - $41,213	-1,629 Reduced 17.14%	7,877 $187,000
Q1 2022 May 12, 2022	SELL	$16.53 - $25.21 $465,980 - $710,669	-28,190 Reduced 74.78%	9,506 $214,000
Q4 2021 Jan 28, 2022	SELL	$17.1 - $23.34 $620,798 - $847,335	-36,304 Reduced 49.06%	37,696 $746,000
Q3 2021 Nov 04, 2021	SELL	$19.68 - $22.53 $3.43 Million - $3.92 Million	-174,100 Reduced 70.17%	74,000 $1.46 Million

Q2 2021 Aug 04, 2021	SELL	$19.97 - $24.43 $2.91 Million - $3.56 Million	-145,800 Reduced 37.01%	248,100 $5.46 Million
Q1 2021 Apr 30, 2021	SELL	$23.49 - $30.56 $7.67 Million - $9.98 Million	-326,500 Reduced 45.32%	393,900 $9.37 Million
Q4 2020 Feb 08, 2021	SELL	$16.78 - $27.3 $14.5 Million - $23.6 Million	-864,500 Reduced 54.55%	720,400 $18.8 Million
Q3 2020 Oct 23, 2020	SELL	$12.46 - $19.98 $687,555 - $1.1 Million	-55,181 Reduced 3.36%	1,584,900 $27.6 Million
Q2 2020 Aug 05, 2020	SELL	$11.0 - $18.26 $2.68 Million - $4.45 Million	-243,543 Reduced 12.93%	1,640,081 $27.6 Million
Q1 2020 May 07, 2020	BUY	$10.11 - $14.04 $1.67 Million - $2.32 Million	165,200 Added 9.61%	1,883,624 $22.4 Million
Q4 2019 Feb 10, 2020	BUY	$12.06 - $16.96 $7.59 Million - $10.7 Million	629,038 Added 57.74%	1,718,424 $20.8 Million
Q3 2019 Nov 07, 2019	BUY	$10.41 - $14.66 $5.56 Million - $7.83 Million	534,286 Added 96.25%	1,089,386 $15.4 Million
Q2 2019 Aug 08, 2019	BUY	$9.78 - $12.76 $4.32 Million - $5.64 Million	442,200 Added 391.67%	555,100 $6.19 Million
Q4 2018 Feb 05, 2019	BUY	$11.29 - $17.19 $1.27 Million - $1.94 Million	112,900 New	112,900 $1.51 Million

Others Institutions Holding CORT

# of Institutions

473

Shares Held

80.2M

Call Options Held

596K

Put Options Held

710K

Black Rock Inc. New York, NY

16.5M
Shares

$1.25 Billion
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

9.54M
Shares

$720 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

7.7M
Shares

$582 Million
20.92% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.09M
Shares

$460 Million
0.72% of portfolio
Parallel Advisors, LLC

3.87M
Shares

$292 Million
6.09% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account